Filter your search
Biotechnology markets include the tools, consumables, services and intellectual property necessary for life sciences and applied medical research. The products of such research include biopharmaceuticals, vaccines, and other biologics. Emerging markets like that of mass spectrometry used in clinical testing applications highlight technological advances that urge more companies to make deals in the field of biotechnology. As the industry grows, companies will develop and integrate automated platforms and diagnostic kits that greatly increase convenience and reliability. This efficiency-mindedness had permeated the past decade in the biotechnology field, as the pace and breadth of translational or biomedical research has created multi-billion dollar markets for research tools and services as well as for the discovered and subsequently marketed biologics. In the future, companies hope to see convenient clinical diagnostic applications eventually coming into multiple areas of the clinical lab.
Next Generation Sequencing
Proteomics
Biopharmaceuticals
Instrumentation & Equipment
Emerging Technologies
-
$5,000.00 – $10,000.00Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated […]December 29, 2023$5,000.00 – $10,000.00The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of […]September 8, 2023$5,000.00 – $10,000.00The Market for Single Cell Analysis in Genomics: Next-Generation Sequencing and Other Technology, 2023-2027 focuses on the market for single cell genomics products. Analyzed are the hardware, service of the hardware, software, and consumables included for the sequencing step and other types of downstream analysis. Single cell RNA-seq enables new types of analyses, for instance: […]April 3, 2023$6,000.00 – $12,000.00Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other […]December 29, 2022$0.00 – $9,000.00The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of […]September 7, 2022$7,500.00This report, produced by Bioinformatics Inc. (not part of Kalorama subscriptions) is a recent survey of 350 respondents from North America, Europe and Asia Pacific that use social media and/or science-related websites for personal or professional purposes participated in this study Readers of this study will understand: Understand the technologies used for isolation of single cells […]August 29, 2022$6,000.00 – $12,000.00Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027 focuses on the market for single cell genomics products — the hardware, service of the hardware, software, and consumables including for the sequencing step and other types of downstream analysis. It discusses trends, challenges, strategies, companies, and products, and […]May 5, 2022$5,000.00 – $10,000.00This report, The World Liquid Biopsy Market, 2021, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid Biopsy The Market for ctDNA-based Liquid Biopsy […]January 6, 2022How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions. It can be a daunting […]Twice Monthly | 20+ Pages$3,000.00 – $6,000.00Viral vectors are useful tools used by molecular biologists to delivery genetic material into cells. Kalorama Information’s Viral Vectors Market Analysis and Opportunities reveals that viral vectors comprise a rising market that is expected to continue to grow as usage increases and novel technologies enter the market. Viral vectors are the most effective means of […]December 20, 2021